Medtech innovator wins two business awards WOLVERHAMPTON-BASED MEDTECH COMPANY Medical Devices Technology International (MDTi) has won two regional business prizes.
Following a highly successful year, MDTi received the Business of the Year and Business Growth Awards at the annual African Caribbean Business Federation event at Brierley Hill’s Copthorne Hotel.
MDTi was started in 2005 by its CEO, former banker Martin Levermore. His strategy was to license NHS-based intellectual property. A licensing arrangement with the Royal Wolverhampton NHS Hospitals Trust enabled MDTi to sub-contract product manufacturing and develop routes to market.
In the last year, two MDTi products have become established in the global marketplace: the ‘Hook-It’, an intravenous drip solution that eliminates the need for hazardous drip stands, and the Physiomaster, an inflatable cushion that helps reduce the risk of deep vein thrombosis.
“We are passionate in what we do and are committed to taking good ideas and turning them into reality for the good of patients locally, nationally and throughout the world,” said Martin Levermore.
“Winning the two ACBF Awards is testament to the fact we can turn innovation into commercial reality and, in addition to improving patient care, we are also creating jobs and adding value to the local economy.”
New MES Manager joins Siemens Healthcare SIEMENS HEALTHCARE has appointed Malbinder Assi as Managed Equipment Services (MES) Manager at the Queen’s Hospital site of Barking, Havering and Redbridge Hospitals NHS Trust.
The MES agreement between Siemens Healthcare and Queen’s Hospital covers the maintenance and management of all medical equipment until 2036. Malbinder’s role will include running the MES department, monitoring monthly equipment performance and implementing the investment plans to deliver the technology required.
Before joining Siemens, Malbinder was a Senior Engineer at Draeger Medical UK, where she looked after equipment maintenance at two sites in Hammersmith for Imperial College Healthcare NHS Trust. She has worked for United Medical Enterprise (UME) Services as an equipment specialist involved in PFI projects, and for GE Clinical Services/ Telematic Biomedical Services (TBS) GB as a biomedical team leader.
Malbinder’s new role at Siemens enables her to combine her experience of PFI projects and biomedical engineering. She will manage a team of 10 Siemens personnel on site at the Trust.
“Malbinder is a great asset to the MES team,” said Philip Peace, Business Manager of Managed Equipment Services for Siemens Healthcare. “We look forward to her contribution in leading our Barking, Havering and Redbridge Hospitals onsite team and steering our PFI MES agreement to ensure that it meets all targets.”
Cambridge Consultants appoints new Head of Drug Delivery MEDTECH PRODUCT DEVELOPMENT COMPANY CAMBRIDGE CONSULTANTS has appointed David Blakey to lead its Drug Delivery campaign.
Blakey will take the company’s Drug Delivery business forward at a time of rapid growth in the use of innovative technologies to control and target drug therapies.
Cambridge Consultants’ Drug Delivery team has a track record of delivering solutions such as Conix, which uses advanced powder dispersion technologies to deliver drugs into the deep lung. The team’s scope includes inhalation, injection and coating systems.
“Cambridge Consultants has a quite unique level of competence... which, combined with a deep understanding of client needs and market requirements through user-centred design, makes for a compelling product design and development service,” said Blakey. “The company’s credentials in the drug delivery market are well established, and I am excited by the prospect of building on these strong foundations.
“I am also keen to exploit the new possibilities in advanced medical systems... For example, there are fascinating opportunities to address challenges presented by a user-centred design process, from adding electronic control and monitoring to novel drug delivery devices.”
David Ellis, Director of Cambridge Consultants’ Medical Technologies Group, commented: “The medtech sector is becoming increasingly innovative in terms of the application of new technologies, and David’s experience of the drug delivery space together with his fresh perspective will enable us to remain at the leading edge of the field.”